Cell Therapy Technologies Market Size, Trends and Insights By Type (Cell Processing, Cell Preservation, Cell Analysis, Cell Expansion), By Application (Cancer, Cardiovascular Disease, Neurological Disorders, Other Diseases), By Cell Type (T-Cells, Stem Cells, Other Cells) and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2023–2032


Report Code: CMI35705

Published Date: December 2023

Pages: 320+

Category: Healthcare

Report Snapshot

CAGR: 14%
4.6B
2022
4.9B
2023
8.5B
2032

Source: CMI

Study Period: 2023-2032
Fastest Growing Market: Asia-Pacific
Largest Market: Europe

Major Players

  • Thermo Fisher Scientific Inc.
  • GE Healthcare
  • Lonza Group
  • Merck KGaA (MilliporeSigma)
  • Others

Exclusive, in-depth market intelligence can help you increase your Revenue.

Download Sample Pdf

Reports Description

Global Cell Therapy Technologies Market is poised for significant growth from 2023 to 2032, driven by factors such as the increasing prevalence of chronic diseases, advancements in cell therapy research, and the need for innovative treatment options.

The market is expected to achieve a Compound Annual Growth Rate (CAGR) of approximately 14% during this period. In 2023, the market is estimated to be valued at USD 4.9 Billion, and it is projected to reach USD 8.5 Billion by 2032.

Cell therapy technologies play a crucial role in the development and manufacturing of cell-based therapies, contributing to the growth of the market.

The Global Cell Therapy Technologies Market is experiencing growth due to various factors, including:

  • Increasing Prevalence of Chronic Diseases: The rising incidence of chronic diseases such as cancer, cardiovascular disease, diabetes, and neurological disorders has created a significant demand for innovative and effective treatment options. Cell therapies offer the potential to address unmet medical needs in these disease areas, driving the growth of cell therapy technologies.
  • Advancements in Cell Therapy Research: Ongoing research and development in the field of cell therapy, including stem cell therapy and regenerative medicine, have led to breakthroughs in understanding disease mechanisms and developing novel therapeutic approaches. These advancements drive the need for advanced technologies to support the translation of research into clinical applications.
  • Regulatory Support: Regulatory bodies in various regions are increasingly supportive of the development and commercialization of cell-based therapies. Streamlined approval processes and regulatory pathways for cell therapies have created a more favorable environment for market growth.
  • Personalized Medicine: The concept of personalized medicine, where treatments are tailored to individual patients based on their genetic and molecular profiles, has gained prominence. Cell therapy technologies enable the customization of cell-based therapies, improving treatment outcomes and patient-specific care.
  • Aging Population: The global aging population is more susceptible to chronic diseases and age-related conditions. Cell-based therapies offer potential solutions for treating these diseases, contributing to the growth of the market.
  • Investment and Funding: The cell therapy sector has attracted significant investment and funding from governments, private organizations, and venture capitalists. These financial resources support research, development, and commercialization efforts in the field.
  • Ethical Sourcing and Sustainability: There is a growing emphasis on ethical cell sourcing and sustainability in the development of cell therapies. Ethical considerations and environmentally responsible practices are influencing the development and adoption of cell therapy technologies.
  • Collaboration and Partnerships: Collaborations between academic institutions, pharmaceutical companies, biotechnology firms, and research organizations play a crucial role in advancing cell therapy technologies. These partnerships enable the pooling of expertise, resources, and knowledge to accelerate progress.
  • Technological Advancements: Continuous advancements in cell processing, cell expansion, cell preservation, and cell analysis technologies have improved the efficiency, safety, and scalability of cell therapy manufacturing. Innovations in automation, closed systems, and analytical tools contribute to market growth.
  • Patient Advocacy and Awareness: Increased awareness among patients about the potential benefits of cell therapies has driven demand for these treatments. Patient advocacy groups and initiatives have played a role in educating the public about the availability and potential of cell-based therapies.
  • Supportive Infrastructure: The development of infrastructure, including specialized manufacturing facilities and research centers dedicated to cell therapy, has facilitated the growth of the industry.
  • Clinical Success Stories: Successful clinical trials and case studies demonstrating the effectiveness of cell therapies in treating various diseases have bolstered confidence in the field, attracting more attention and investment.
  • Global Expansion: The cell therapy market is expanding globally, with emerging markets in Asia, Latin America, and other regions actively participating in research and development efforts. This global expansion contributes to the market’s overall growth.
  • Increasing Adoption of CAR-T and Gene Therapies: Chimeric Antigen Receptor T-cell (CAR-T) therapies and gene therapies, both of which rely on cell-based approaches, are gaining acceptance in the treatment of cancer and genetic disorders. The adoption of these therapies is propelling the cell therapy technologies market forward.
  • Growing Clinical Evidence: The accumulation of clinical evidence showcasing the safety and efficacy of cell therapies in a variety of clinical applications has instilled confidence in healthcare providers, regulators, and patients, promoting the growth of the market.

Global Cell Therapy Technologies Market – Mergers and Acquisitions

Thermo Fisher Scientific’s Acquisition of Qiagen (2020):

  • Thermo Fisher Scientific, a leading life sciences company, acquired Qiagen, a global provider of molecular diagnostics and sample preparation technologies.
  • This acquisition expanded Thermo Fisher’s capabilities in molecular biology and sample preparation, providing them with valuable tools for cell therapy research and development.
  • The deal represented a significant move to strengthen Thermo Fisher’s position in the life sciences and healthcare sectors, supporting its growth in the cell therapy technologies market.

Miltenyi Biotec’s Acquisition of Owl Biomedical (2015):

  • Miltenyi Biotec, a provider of cell therapy tools and solutions, acquired Owl Biomedical, a company specializing in microchip-based cell sorting systems.
  • This acquisition allowed Miltenyi Biotec to enhance its cell sorting technology portfolio, which is crucial for cell therapy research and manufacturing.
  • The integration of Owl Biomedical’s expertise and technology into Miltenyi Biotec’s offerings positioned the company as a leader in cell therapy technologies.

Repligen Corporation’s Acquisition of ARTeSYN Biosolutions (2021):

  • Repligen Corporation, a life sciences company, acquired ARTeSYN Biosolutions, a manufacturer of single-use systems for the biopharmaceutical industry.
  • This acquisition complemented Repligen’s offerings in bioprocessing technologies, including those used in cell therapy manufacturing.
  • The integration of ARTeSYN Biosolutions’ expertise and products strengthened Repligen’s capabilities in automated manufacturing for cell therapy products.

Lonza Group’s Partnership with Sheba Medical Center (2022):

  • Lonza Group, a biotechnology company, formed a strategic partnership with Sheba Medical Center in Israel to establish a center for cell and gene therapy manufacturing.
  • This collaboration aims to advance the development and production of cell-based therapies, including cell and gene therapies, and contribute to the growth of the global cell therapy technologies market.
  • The partnership showcases the importance of research and development collaborations to drive innovation in cell therapy technologies.

STEMCELL Technologies Acquisition of Vanrx Pharmasystems (2020):

  • STEMCELL Technologies, a provider of tools and solutions for cell culture and cell therapy, acquired Vanrx Pharmasystems, a company specializing in aseptic filling and robotic manufacturing systems.
  • This acquisition expanded STEMCELL Technologies’ capabilities in automated manufacturing for cell therapy products, offering more advanced and efficient manufacturing solutions.
  • The deal reinforced STEMCELL Technologies’ commitment to providing cutting-edge tools for cell therapy research and development.

COMPARATIVE ANALYSIS OF THE RELATED MARKET

Cell Therapy Technologies Market Animal Parasiticides Market Organ Transplantation Market
CAGR 14% (Approx) CAGR 5.9% (Approx) CAGR 9.5% (Approx)
USD 8.5 Billion by 2032 USD 16.98 Billion by 2032 USD 21.5 Billion by 2032

Challenges Impacting the Cell Therapy Technologies Market:

  • Complex Manufacturing Processes: The manufacturing of cell-based therapies is often intricate and requires precise control over various parameters, including cell sourcing, expansion, differentiation, and quality control. Maintaining consistency and ensuring product quality across batches can be challenging.
  • Regulatory Compliance: Developing cell therapies involves navigating complex and evolving regulatory frameworks. Ensuring that products meet safety and efficacy standards, gaining regulatory approvals, and adhering to Good Manufacturing Practices (GMP) can be time-consuming and resource-intensive.
  • Cost of Therapy: Cell therapy development and manufacturing can be costly, which may impact accessibility for patients and healthcare systems. Reducing the cost of goods and the overall cost of therapy remains a significant challenge.
  • Patient-Specific Challenges: Customizing cell therapies to individual patients requires personalized approaches, making scalability, and logistical challenges key concerns. Creating affordable and efficient processes for patient-specific treatments is a hurdle.
  • Supply Chain Management: Ensuring the timely and secure transportation of cell therapy products from manufacturing facilities to treatment centers or clinics is a logistical challenge. Maintaining temperature and quality control throughout the supply chain is critical.
  • Ethical and Safety Concerns: Ethical considerations, especially regarding the use of stem cells and genetic modifications, as well as safety concerns related to potential adverse events, can influence public perception and acceptance of cell therapies.
  • Competitive Landscape: As the cell therapy market grows, competition among technology providers intensifies. Established and emerging companies are vying for a share of the market, driving innovation but also creating challenges related to market saturation.
  • Educational and Training Needs: Developing and manufacturing cell therapies require specialized knowledge and expertise. The industry needs to invest in training professionals to meet the increasing demand for skilled personnel.
  • Tissue Sourcing and Availability: Sourcing suitable cells or tissues for therapy can be constrained by ethical considerations and availability. The challenge lies in ensuring a reliable and ethical supply of raw materials for cell therapy production.
  • Technological Advancements: Cell therapy technologies must continually evolve to adapt to new scientific discoveries and innovations in the field. Keeping up with evolving technologies and scientific advancements is crucial for staying competitive and compliant with regulatory standards.
  • Clinical Evidence: Generating robust clinical evidence to demonstrate the safety and efficacy of cell therapies across various applications is a time-consuming and resource-intensive process. Building a substantial body of clinical data is essential for gaining market acceptance.
  • Reimbursement and Market Access: Establishing reimbursement strategies and ensuring market access for cell therapies can be challenging. Payers may require convincing evidence of cost-effectiveness and clinical benefit.
  • Patents and Intellectual Property: Intellectual property and patent disputes can affect market dynamics, particularly when different companies claim ownership of similar technologies or cell therapy products.
  • Long-Term Safety and Efficacy: Ensuring the long-term safety and efficacy of cell therapies is crucial, especially for treatments designed to provide durable and sustainable benefits. Monitoring patients over extended periods is necessary to assess long-term outcomes.

Report Scope

Feature of the Report Details
Market Size in 2023 USD 4.9 Billion
Projected Market Size in 2032 USD 8.5 Billion
Market Size in 2022 USD 4.6 Billion
CAGR Growth Rate 14% CAGR
Base Year 2022
Forecast Period 2023-2032
Key Segment By Type, Application and Region
Report Coverage Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends
Regional Scope North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America
Buying Options Request tailored purchasing options to fulfil your requirements for research.

Category-wise Analysis:

By Type:

  • Cell Processing: Technologies and equipment used in the processing and manipulation of cells for cell-based therapies.
  • Cell Preservation: Solutions and methods for preserving cells for extended periods, ensuring their viability.
  • Cell Analysis: Tools and instruments for analyzing cell characteristics, quality, and safety.
  • Cell Expansion: Techniques and systems for expanding cell populations for therapy.

Global Cell Therapy Technologies Market 2023–2032 (By Billion)

www.custommarketinsight.com

By Application:

  • Cancer: Cell-based therapies for the treatment of various types of cancer.
  • Cardiovascular Disease: Cell therapies targeting cardiovascular conditions and heart diseases.
  • Neurological Disorders: Treatment options for neurological and neurodegenerative disorders.
  • Other Diseases: Cell therapy applications in a wide range of medical conditions beyond the above categories.

Global Cell Therapy Technologies Market 2023–2032 (By Cell Type)

www.custommarketinsight.com

Cell Therapy Technologies Market – Regional Analysis:

North America:

  • United States: The United States is a major player in the global cell therapy technologies market. It has a strong emphasis on research, development, and manufacturing of cell therapies, particularly in the areas of cancer, cardiovascular diseases, and neurology. The U.S. regulatory environment is supportive of cell therapy innovation, and the country boasts a diverse range of service providers and research institutions.
  • Canada: Canada also contributes to cell therapy research and development, with a focus on financing, human resources, and technology services. The country supports businesses in a competitive environment and contributes to the sustainability efforts of the region.

Europe:

  • Western Europe: Western European countries such as the United Kingdom, Germany, and France lead in consulting and technology services for cell therapy technologies. The market in Western Europe is driven by digital transformation and environmental, social, and governance (ESG) initiatives.
  • Eastern Europe: Eastern European nations are increasingly adopting outsourcing services, especially in information technology (IT) and finance, attracting businesses looking for cost-effective solutions.

Asia-Pacific:

  • China: China’s cell therapy market is growing rapidly, driven by technology services and consulting. The market is characterized by a focus on innovation and digital transformation, aligning with China’s ambitions in the electric vehicle and renewable energy sectors.
  • India: India is a prominent outsourcing hub, providing a wide range of services, including IT, finance, and customer support, to global businesses. The Indian market supports cell therapy research and development efforts in the region.
  • Southeast Asia: Southeast Asian countries offer outsourcing and technology services, catering to the needs of businesses looking for cost-effective solutions and a skilled workforce.

Latin America:

  • Brazil: Brazil’s cell therapy market emphasizes outsourcing and consulting services, serving a diverse range of industries and businesses.
  • Mexico: Mexico’s market focuses on finance and technology services, attracting businesses seeking specialized expertise and cost-effective solutions.

Middle East and Africa:

  • Middle East: Middle Eastern countries provide technology and consulting services to support businesses in various sectors, including oil and gas, finance, and technology.
  • Africa: African nations are emerging as outsourcing destinations, with a focus on IT and customer support services, contributing to the growth of the cell therapy technologies market.

Oceania:

  • Australia: Australia’s cell therapy market concentrates on technology services and consulting. It serves businesses in a competitive business landscape, aligning with the country’s focus on sustainability and renewable energy adoption.

Global Cell Therapy Technologies Market 2023–2032 (By Type)

www.custommarketinsight.com

List of the prominent players in the Cell Therapy Technologies Market:

  • Thermo Fisher Scientific Inc.
  • GE Healthcare
  • Lonza Group
  • Merck KGaA (MilliporeSigma)
  • Terumo BCT (Terumo Corporation)
  • STEMCELL Technologies Inc.
  • Sartorius AG
  • Therakos Inc. (Mallinckrodt Pharmaceuticals)
  • Miltenyi Biotec
  • Fresenius Kabi AG
  • Pluristem Therapeutics Inc.
  • MaxCyte Inc.
  • CellGenix GmbH
  • Novartis International AG
  • Gilead Sciences Inc.
  • Others

The Cell Therapy Technologies Market is segmented as follows:

By Type

  • Cell Processing
  • Cell Preservation
  • Cell Analysis
  • Cell Expansion

By Application

  • Cancer
  • Cardiovascular Disease
  • Neurological Disorders
  • Other Diseases

By Cell Type

  • T-Cells
  • Stem Cells
  • Other Cells

Regional Coverage:

North America

  • U.S.
  • Canada
  • Mexico
  • Rest of North America

Europe

  • Germany
  • France
  • U.K.
  • Russia
  • Italy
  • Spain
  • Netherlands
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • New Zealand
  • Australia
  • South Korea
  • Taiwan
  • Rest of Asia Pacific

The Middle East & Africa

  • Saudi Arabia
  • UAE
  • Egypt
  • Kuwait
  • South Africa
  • Rest of the Middle East & Africa

Latin America

  • Brazil
  • Argentina
  • Rest of Latin America

Table of Contents

  • Chapter 1. Preface
    • 1.1 Report Description and Scope
    • 1.2 Research scope
    • 1.3 Research Methodology
      • 1.3.1 Market Research Type
      • 1.3.2 Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1 Global Cell Therapy Technologies Market, (2023 – 2032) (USD Billion)
    • 2.2 Global Cell Therapy Technologies Market: snapshot
  • Chapter 3. Global Cell Therapy Technologies Market – Industry Analysis
    • 3.1 Cell Therapy Technologies Market: Market Dynamics
    • 3.2 Market Drivers
      • 3.2.1 Increasing Prevalence of Chronic Diseases
      • 3.2.2 Advancements in Cell Therapy Research
      • 3.2.3 Regulatory Support
      • 3.2.4 Personalized Medicine
      • 3.2.5 Aging Population
      • 3.2.6 Investment and Funding
      • 3.2.7 Ethical Sourcing and Sustainability
      • 3.2.8 Collaboration and Partnerships
      • 3.2.9 Technological Advancements
      • 3.2.10 Patient Advocacy and Awareness
      • 3.2.11 Supportive Infrastructure
      • 3.2.12 Clinical Success Stories
      • 3.2.13 Global Expansion
      • 3.2.14 Increasing Adoption of CAR-T and Gene Therapies
      • 3.2.15 Growing Clinical Evidence.
    • 3.3 Market Restraints
    • 3.4 Market Opportunities
    • 3.5 Market Challenges
    • 3.6 Porter’s Five Forces Analysis
    • 3.7 Market Attractiveness Analysis
      • 3.7.1 Market Attractiveness Analysis By Type
      • 3.7.2 Market Attractiveness Analysis By Application
      • 3.7.3 Market Attractiveness Analysis By Cell Type
  • Chapter 4. Global Cell Therapy Technologies Market- Competitive Landscape
    • 4.1 Company market share analysis
      • 4.1.1 Global Cell Therapy Technologies Market: company market share, 2022
    • 4.2 Strategic development
      • 4.2.1 Acquisitions & mergers
      • 4.2.2 New Product launches
      • 4.2.3 Agreements, partnerships, collaboration, and joint ventures
      • 4.2.4 Research and development and Regional expansion
    • 4.3 Price trend analysis
  • Chapter 5. Global Cell Therapy Technologies Market – Type Analysis
    • 5.1 Global Cell Therapy Technologies Market Overview: By Type
      • 5.1.1 Global Cell Therapy Technologies Market Share, By Type, 2022 and 2032
    • 5.2 Cell Processing
      • 5.2.1 Global Cell Therapy Technologies Market by Cell Processing, 2023 – 2032 (USD Billion)
    • 5.3 Cell Preservation
      • 5.3.1 Global Cell Therapy Technologies Market by Cell Preservation, 2023 – 2032 (USD Billion)
    • 5.4 Cell Analysis
      • 5.4.1 Global Cell Therapy Technologies Market by Cell Analysis, 2023 – 2032 (USD Billion)
    • 5.5 Cell Expansion
      • 5.5.1 Global Cell Therapy Technologies Market by Cell Expansion, 2023 – 2032 (USD Billion)
  • Chapter 6. Global Cell Therapy Technologies Market – Application Analysis
    • 6.1 Global Cell Therapy Technologies Market Overview: By Application
      • 6.1.1 Global Cell Therapy Technologies Market Share, By Application, 2022 and 2032
    • 6.2 Cancer
      • 6.2.1 Global Cell Therapy Technologies Market by Cancer, 2023 – 2032 (USD Billion)
    • 6.3 Cardiovascular Disease
      • 6.3.1 Global Cell Therapy Technologies Market by Cardiovascular Disease, 2023 – 2032 (USD Billion)
    • 6.4 Neurological Disorders
      • 6.4.1 Global Cell Therapy Technologies Market by Neurological Disorders, 2023 – 2032 (USD Billion)
    • 6.5 Other Diseases
      • 6.5.1 Global Cell Therapy Technologies Market by Other Diseases, 2023 – 2032 (USD Billion)
  • Chapter 7. Global Cell Therapy Technologies Market – Cell Type Analysis
    • 7.1 Global Cell Therapy Technologies Market Overview: By Cell Type
      • 7.1.1 Global Cell Therapy Technologies Market Share, By Cell Type, 2022 and 2032
    • 7.2 T-Cells
      • 7.2.1 Global Cell Therapy Technologies Market by T-Cells, 2023 – 2032 (USD Billion)
    • 7.3 Stem Cells
      • 7.3.1 Global Cell Therapy Technologies Market by Stem Cells, 2023 – 2032 (USD Billion)
    • 7.4 Other Cells
      • 7.4.1 Global Cell Therapy Technologies Market by Other Cells, 2023 – 2032 (USD Billion)
  • Chapter 8. Cell Therapy Technologies Market – Regional Analysis
    • 8.1 Global Cell Therapy Technologies Market Regional Overview
    • 8.2 Global Cell Therapy Technologies Market Share, by Region, 2022 & 2032 (USD Billion)
    • 8.3. North America
      • 8.3.1 North America Cell Therapy Technologies Market, 2023 – 2032 (USD Billion)
        • 8.3.1.1 North America Cell Therapy Technologies Market, by Country, 2023 – 2032 (USD Billion)
    • 8.4 North America Cell Therapy Technologies Market, by Type, 2023 – 2032
      • 8.4.1 North America Cell Therapy Technologies Market, by Type, 2023 – 2032 (USD Billion)
    • 8.5 North America Cell Therapy Technologies Market, by Application, 2023 – 2032
      • 8.5.1 North America Cell Therapy Technologies Market, by Application, 2023 – 2032 (USD Billion)
    • 8.6 North America Cell Therapy Technologies Market, by Cell Type, 2023 – 2032
      • 8.6.1 North America Cell Therapy Technologies Market, by Cell Type, 2023 – 2032 (USD Billion)
    • 8.7. Europe
      • 8.7.1 Europe Cell Therapy Technologies Market, 2023 – 2032 (USD Billion)
        • 8.7.1.1 Europe Cell Therapy Technologies Market, by Country, 2023 – 2032 (USD Billion)
    • 8.8 Europe Cell Therapy Technologies Market, by Type, 2023 – 2032
      • 8.8.1 Europe Cell Therapy Technologies Market, by Type, 2023 – 2032 (USD Billion)
    • 8.9 Europe Cell Therapy Technologies Market, by Application, 2023 – 2032
      • 8.9.1 Europe Cell Therapy Technologies Market, by Application, 2023 – 2032 (USD Billion)
    • 8.10 Europe Cell Therapy Technologies Market, by Cell Type, 2023 – 2032
      • 8.10.1 Europe Cell Therapy Technologies Market, by Cell Type, 2023 – 2032 (USD Billion)
    • 8.11. Asia Pacific
      • 8.11.1 Asia Pacific Cell Therapy Technologies Market, 2023 – 2032 (USD Billion)
        • 8.11.1.1 Asia Pacific Cell Therapy Technologies Market, by Country, 2023 – 2032 (USD Billion)
    • 8.12 Asia Pacific Cell Therapy Technologies Market, by Type, 2023 – 2032
      • 8.12.1 Asia Pacific Cell Therapy Technologies Market, by Type, 2023 – 2032 (USD Billion)
    • 8.13 Asia Pacific Cell Therapy Technologies Market, by Application, 2023 – 2032
      • 8.13.1 Asia Pacific Cell Therapy Technologies Market, by Application, 2023 – 2032 (USD Billion)
    • 8.14 Asia Pacific Cell Therapy Technologies Market, by Cell Type, 2023 – 2032
      • 8.14.1 Asia Pacific Cell Therapy Technologies Market, by Cell Type, 2023 – 2032 (USD Billion)
    • 8.15. Latin America
      • 8.15.1 Latin America Cell Therapy Technologies Market, 2023 – 2032 (USD Billion)
        • 8.15.1.1 Latin America Cell Therapy Technologies Market, by Country, 2023 – 2032 (USD Billion)
    • 8.16 Latin America Cell Therapy Technologies Market, by Type, 2023 – 2032
      • 8.16.1 Latin America Cell Therapy Technologies Market, by Type, 2023 – 2032 (USD Billion)
    • 8.17 Latin America Cell Therapy Technologies Market, by Application, 2023 – 2032
      • 8.17.1 Latin America Cell Therapy Technologies Market, by Application, 2023 – 2032 (USD Billion)
    • 8.18 Latin America Cell Therapy Technologies Market, by Cell Type, 2023 – 2032
      • 8.18.1 Latin America Cell Therapy Technologies Market, by Cell Type, 2023 – 2032 (USD Billion)
    • 8.19. The Middle East and Africa
      • 8.19.1 The Middle-East and Africa Cell Therapy Technologies Market, 2023 – 2032 (USD Billion)
        • 8.19.1.1 The Middle-East and Africa Cell Therapy Technologies Market, by Country, 2023 – 2032 (USD Billion)
    • 8.20 The Middle-East and Africa Cell Therapy Technologies Market, by Type, 2023 – 2032
      • 8.20.1 The Middle-East and Africa Cell Therapy Technologies Market, by Type, 2023 – 2032 (USD Billion)
    • 8.21 The Middle-East and Africa Cell Therapy Technologies Market, by Application, 2023 – 2032
      • 8.21.1 The Middle-East and Africa Cell Therapy Technologies Market, by Application, 2023 – 2032 (USD Billion)
    • 8.22 The Middle-East and Africa Cell Therapy Technologies Market, by Cell Type, 2023 – 2032
      • 8.22.1 The Middle-East and Africa Cell Therapy Technologies Market, by Cell Type, 2023 – 2032 (USD Billion)
  • Chapter 9. Company Profiles
    • 9.1 Thermo Fisher Scientific Inc.
      • 9.1.1 Overview
      • 9.1.2 Financials
      • 9.1.3 Product Portfolio
      • 9.1.4 Business Strategy
      • 9.1.5 Recent Developments
    • 9.2 GE Healthcare
      • 9.2.1 Overview
      • 9.2.2 Financials
      • 9.2.3 Product Portfolio
      • 9.2.4 Business Strategy
      • 9.2.5 Recent Developments
    • 9.3 Lonza Group
      • 9.3.1 Overview
      • 9.3.2 Financials
      • 9.3.3 Product Portfolio
      • 9.3.4 Business Strategy
      • 9.3.5 Recent Developments
    • 9.4 Merck KGaA (MilliporeSigma)
      • 9.4.1 Overview
      • 9.4.2 Financials
      • 9.4.3 Product Portfolio
      • 9.4.4 Business Strategy
      • 9.4.5 Recent Developments
    • 9.5 Terumo BCT (Terumo Corporation)
      • 9.5.1 Overview
      • 9.5.2 Financials
      • 9.5.3 Product Portfolio
      • 9.5.4 Business Strategy
      • 9.5.5 Recent Developments
    • 9.6 STEMCELL Technologies Inc.
      • 9.6.1 Overview
      • 9.6.2 Financials
      • 9.6.3 Product Portfolio
      • 9.6.4 Business Strategy
      • 9.6.5 Recent Developments
    • 9.7 Sartorius AG
      • 9.7.1 Overview
      • 9.7.2 Financials
      • 9.7.3 Product Portfolio
      • 9.7.4 Business Strategy
      • 9.7.5 Recent Developments
    • 9.8 Therakos Inc. (Mallinckrodt Pharmaceuticals)
      • 9.8.1 Overview
      • 9.8.2 Financials
      • 9.8.3 Product Portfolio
      • 9.8.4 Business Strategy
      • 9.8.5 Recent Developments
    • 9.9 Miltenyi Biotec
      • 9.9.1 Overview
      • 9.9.2 Financials
      • 9.9.3 Product Portfolio
      • 9.9.4 Business Strategy
      • 9.9.5 Recent Developments
    • 9.10 Fresenius Kabi AG
      • 9.10.1 Overview
      • 9.10.2 Financials
      • 9.10.3 Product Portfolio
      • 9.10.4 Business Strategy
      • 9.10.5 Recent Developments
    • 9.11 Pluristem Therapeutics Inc.
      • 9.11.1 Overview
      • 9.11.2 Financials
      • 9.11.3 Product Portfolio
      • 9.11.4 Business Strategy
      • 9.11.5 Recent Developments
    • 9.12 MaxCyte Inc.
      • 9.12.1 Overview
      • 9.12.2 Financials
      • 9.12.3 Product Portfolio
      • 9.12.4 Business Strategy
      • 9.12.5 Recent Developments
    • 9.13 CellGenix GmbH
      • 9.13.1 Overview
      • 9.13.2 Financials
      • 9.13.3 Product Portfolio
      • 9.13.4 Business Strategy
      • 9.13.5 Recent Developments
    • 9.14 Novartis International AG
      • 9.14.1 Overview
      • 9.14.2 Financials
      • 9.14.3 Product Portfolio
      • 9.14.4 Business Strategy
      • 9.14.5 Recent Developments
    • 9.15 Gilead Sciences Inc.
      • 9.15.1 Overview
      • 9.15.2 Financials
      • 9.15.3 Product Portfolio
      • 9.15.4 Business Strategy
      • 9.15.5 Recent Developments
    • 9.16 Others.
      • 9.16.1 Overview
      • 9.16.2 Financials
      • 9.16.3 Product Portfolio
      • 9.16.4 Business Strategy
      • 9.16.5 Recent Developments
List Of Figures

Figures No 1 to 27

List Of Tables

Tables No 1 to 77

Report Methodology

In order to get the most precise estimates and forecasts possible, Custom Market Insights applies a detailed and adaptive research methodology centered on reducing deviations. For segregating and assessing quantitative aspects of the market, the company uses a combination of top-down and bottom-up approaches. Furthermore, data triangulation, which examines the market from three different aspects, is a recurring theme in all of our research reports. The following are critical components of the methodology used in all of our studies:

Preliminary Data Mining

On a broad scale, raw market information is retrieved and compiled. Data is constantly screened to make sure that only substantiated and verified sources are taken into account. Furthermore, data is mined from a plethora of reports in our archive and also a number of reputed & reliable paid databases. To gain a detailed understanding of the business, it is necessary to know the entire product life cycle and to facilitate this, we gather data from different suppliers, distributors, and buyers.

Surveys, technological conferences, and trade magazines are used to identify technical issues and trends. Technical data is also gathered from the standpoint of intellectual property, with a focus on freedom of movement and white space. The dynamics of the industry in terms of drivers, restraints, and valuation trends are also gathered. As a result, the content created contains a diverse range of original data, which is then cross-validated and verified with published sources.

Statistical Model

Simulation models are used to generate our business estimates and forecasts. For each study, a one-of-a-kind model is created. Data gathered for market dynamics, the digital landscape, development services, and valuation patterns are fed into the prototype and analyzed concurrently. These factors are compared, and their effect over the projected timeline is quantified using correlation, regression, and statistical modeling. Market forecasting is accomplished through the use of a combination of economic techniques, technical analysis, industry experience, and domain knowledge.

Short-term forecasting is typically done with econometric models, while long-term forecasting is done with technological market models. These are based on a synthesis of the technological environment, legal frameworks, economic outlook, and business regulations. Bottom-up market evaluation is favored, with crucial regional markets reviewed as distinct entities and data integration to acquire worldwide estimates. This is essential for gaining a thorough knowledge of the industry and ensuring that errors are kept to a minimum.

Some of the variables taken into account for forecasting are as follows:

• Industry drivers and constraints, as well as their current and projected impact

• The raw material case, as well as supply-versus-price trends

• Current volume and projected volume growth through 2030

We allocate weights to these variables and use weighted average analysis to determine the estimated market growth rate.

Primary Validation

This is the final step in our report’s estimating and forecasting process. Extensive primary interviews are carried out, both in-person and over the phone, to validate our findings and the assumptions that led to them.
Leading companies from across the supply chain, including suppliers, technology companies, subject matter experts, and buyers, use techniques like interviewing to ensure a comprehensive and non-biased overview of the business. These interviews are conducted all over the world, with the help of local staff and translators, to overcome language barriers.

Primary interviews not only aid with data validation, but also offer additional important insight into the industry, existing business scenario, and future projections, thereby improving the quality of our reports.

All of our estimates and forecasts are validated through extensive research work with key industry participants (KIPs), which typically include:

• Market leaders

• Suppliers of raw materials

• Suppliers of raw materials

• Buyers.

The following are the primary research objectives:

• To ensure the accuracy and acceptability of our data.

• Gaining an understanding of the current market and future projections.

Data Collection Matrix

Perspective Primary research Secondary research
Supply-side
  • Manufacturers
  • Technology distributors and wholesalers
  • Company reports and publications
  • Government publications
  • Independent investigations
  • Economic and demographic data
Demand-side
  • End-user surveys
  • Consumer surveys
  • Mystery shopping
  • Case studies
  • Reference customers


Market Analysis Matrix

Qualitative analysis Quantitative analysis
  • Industry landscape and trends
  • Market dynamics and key issues
  • Technology landscape
  • Market opportunities
  • Porter’s analysis and PESTEL analysis
  • Competitive landscape and component benchmarking
  • Policy and regulatory scenario
  • Market revenue estimates and forecast up to 2030
  • Market revenue estimates and forecasts up to 2030, by technology
  • Market revenue estimates and forecasts up to 2030, by application
  • Market revenue estimates and forecasts up to 2030, by type
  • Market revenue estimates and forecasts up to 2030, by component
  • Regional market revenue forecasts, by technology
  • Regional market revenue forecasts, by application
  • Regional market revenue forecasts, by type
  • Regional market revenue forecasts, by component

Prominent Player

  • Thermo Fisher Scientific Inc.
  • GE Healthcare
  • Lonza Group
  • Merck KGaA (MilliporeSigma)
  • Terumo BCT (Terumo Corporation)
  • STEMCELL Technologies Inc.
  • Sartorius AG
  • Therakos Inc. (Mallinckrodt Pharmaceuticals)
  • Miltenyi Biotec
  • Fresenius Kabi AG
  • Pluristem Therapeutics Inc.
  • MaxCyte Inc.
  • CellGenix GmbH
  • Novartis International AG
  • Gilead Sciences Inc.
  • Others

FAQs

The key factors driving the Market are Increasing Prevalence of Chronic Diseases, Advancements in Cell Therapy Research, Regulatory Support, Personalized Medicine, Aging Population, Investment and Funding, Ethical Sourcing and Sustainability, Collaboration and Partnerships, Technological Advancements, Patient Advocacy and Awareness, Supportive Infrastructure, Clinical Success Stories, Global Expansion, Increasing Adoption of CAR-T and Gene Therapies And Growing Clinical Evidence.

The “Cell Processing” category dominated the market in 2022.

The key players in the market are Thermo Fisher Scientific Inc., GE Healthcare, Lonza Group, Merck KGaA (MilliporeSigma), Terumo BCT (Terumo Corporation), STEMCELL Technologies Inc., Sartorius AG, Therakos Inc. (Mallinckrodt Pharmaceuticals), Miltenyi Biotec, Fresenius Kabi AG, Pluristem Therapeutics Inc., MaxCyte Inc., CellGenix GmbH, Novartis International AG, Gilead Sciences Inc., Others.

“North America” had the largest share in the Cell Therapy Technologies Market.

The global market is projected to grow at a CAGR of 14% during the forecast period, 2023-2032.

The Cell Therapy Technologies Market size was valued at USD 4.9 Billion in 2023.

PURCHASE OPTIONS

$

3490


$

4490


$

5490


$

1950


powerbi pdf
$

6200

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • Free 25% or 40 hours of customisation.
  • Free post-sale service assistance.
  • 15% discount on your next purchase.
  • Dedicated account Associate .
  • Permission to print the report.
  • Service guarantee available.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • Free 35% or 60 hours of customisation.
  • Free post-sale service assistance.
  • 25% discount on your next purchase.
  • Service guarantee available.
  • Personalised market brief by author.
  • Permission to print the report.
  • PDF, Excel and Power Point.
  • Can be accessible by unlimited users.
  • Free 40% or 80 hours of customisation.
  • Free post-sale service assistance.
  • 30% discount on your next purchase.
  • Permission to print the report.
  • Dedicated account manager.
  • Service guarantee available.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
  • 15% discount on your next purchase.
  • Free 20% or 10 hours of customisation.
  • PDF, Excel, Power Point and Power BI.
  • Every Year Free Update ( Apr – Apr)
  • Personalized market brief by author
  • Can be accessible by unlimited users.
  • Free 50% or 90 hours of customization.
  • Up to 50 Company Profiles
  • Free post-sale service assistance with guarantee
  • 40% discount on your next purchase.
  • Permission to print the report.
  • Dedicated account team.
  • Service guarantee available.

Want to customize this report?
100% FREE CUSTOMIZATION!